Concerns with the new biological research criteria for synucleinopathy

Affiliations

¹ Movement Disorders Unit, Neurology Service, Virgen de las Nieves University Hospital, Instituto de Investigación Biosanitaria (IBS Granada), Granada 18013, Spain. Electronic address: fescamilla@hotmail.com.
² Hospital General Universitario de Elche, Imed Hospital, Elche, Alicante, Spain.
³ Movement Disorders Unit, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
⁴ Movement Disorders Unit, Hospital 12 de Octubre, Madrid, Spain.
⁵ Movement Disorders Unit, Department of Neurology, A Coruña University Hospital Center, Instituto de Investigación Biomédica de A Coruña, A Coruña, Spain.

Comment

Francisco Escamilla-Sevilla et al. Lancet Neurol. 2024 Jul.

. 2024 Jul;23(7):662.

doi: 10.1016/S1474-4422(24)00214-X.

¹ Movement Disorders Unit, Neurology Service, Virgen de las Nieves University Hospital, Instituto de Investigación Biosanitaria (IBS Granada), Granada 18013, Spain. Electronic address: fescamilla@hotmail.com.
² Hospital General Universitario de Elche, Imed Hospital, Elche, Alicante, Spain.
³ Movement Disorders Unit, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
⁴ Movement Disorders Unit, Hospital 12 de Octubre, Madrid, Spain.
⁵ Movement Disorders Unit, Department of Neurology, A Coruña University Hospital Center, Instituto de Investigación Biomédica de A Coruña, A Coruña, Spain.

No abstract available

Comment in

Concerns with the new biological research criteria for synucleinopathy - Authors' reply.
Simuni T, Chahine LM, Weintraub D, Poston KM, Kopil CM, Dunn B, Marek K. Simuni T, et al. Lancet Neurol. 2024 Jul;23(7):663-666. doi: 10.1016/S1474-4422(24)00233-3. Lancet Neurol. 2024. PMID: 38876741 No abstract available.
Concerns with the new biological research criteria for synucleinopathy - Authors' reply.
Lang AE, Höglinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, Postuma R, Stoessl AJ. Lang AE, et al. Lancet Neurol. 2024 Jul;23(7):666-668. doi: 10.1016/S1474-4422(24)00212-6. Lancet Neurol. 2024. PMID: 38876742 No abstract available.

A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K. Simuni T, et al. Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2. Lancet Neurol. 2024. PMID: 38267190 Review.